Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11602789 | 0.88 | ALDH1A1 (0.62) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| SCHEMBL900830 | 0.83 | ALDH1A1 (0.68) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| SCHEMBL15197918 | 0.83 | ALDH1A1 (0.50) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| SCHEMBL2955775 | 0.82 | ALDH1A1 (0.54) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| SCHEMBL134091 | 0.81 | ALDH1A1 (0.59) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| Hydrogen Peroxide SCHEMBL9514730 | 0.81 | ALDH1A1 (0.59) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| SCHEMBL29657201 | 0.81 | ALDH1A1 (0.59) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| SCHEMBL254364 | 0.81 | ALDH1A1 (0.59) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| Benzene SCHEMBL28132022 | 0.81 | ALDH1A1 (0.59) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| SCHEMBL13123149 | 0.80 | AKR1C3 (0.57) | ALDH1A1GAAKMT2ATDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11220650-B2 | Grease composition | SHELL OIL COMPANY (US) | 2022-01-11 | — | — | US | claimed |
| US-11198830-B2 | Grease composition | SHELL OIL COMPANY (US) | 2021-12-14 | — | — | US | claimed |
| EP-4680706-A1 | BIODEGRADABLE GREASE COMPOSITION | Shell Internationale Research Maatschappij B.V. (NL) | 2026-01-21 | — | — | EP | disclosed |
| EP-3692121-B1 | GREASE COMPOSITION | SHELL INT RESEARCH (NL) | 2023-07-19 | — | — | EP | disclosed |
| WO-2023111683-A1 | N4-HYDROXYCYTIDINE DERIVATIVES AND USE THEREOF AS ANTIVIRAL AGENT | ASCLETIS BIOSCIENCE CO., LTD. (CN) | 2023-06-22 | — | — | WO | disclosed |
| US-11318129-B2 | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders | ARDELYX, INC. (US) | 2022-05-03 | — | — | US | disclosed |
| CN-110023464-B | Grease composition | 国际壳牌研究有限公司 | 2022-02-08 | — | — | CN | disclosed |
| US-11220650-B2 | Grease composition | SHELL OIL COMPANY (US) | 2022-01-11 | — | — | US | disclosed |
| US-11198830-B2 | Grease composition | SHELL OIL COMPANY (US) | 2021-12-14 | — | — | US | disclosed |
| EP-2785821-B1 | GREASE COMPOSITION | SHELL INT RESEARCH (NL) | 2021-03-03 | — | — | EP | disclosed |
| US-20200268741-A1 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | ARDELYX, INC. (US) | 2020-08-27 | — | — | US | disclosed |
| EP-1404335-A1 | AMINO NICOTINATE DERIVATIVES AS GLUCOKINASE (GLK) MODULATORS | Astrazeneca AB (SE) | 2004-04-07 | — | — | EP | disclosed |
| CN-1131252-C | Acrylic-modified waterborne alkyd or urethane-modified alkyd dispersions | EASTMAN CHEM CO (US) | 2003-12-17 | — | — | CN | disclosed |
| WO-2003000267-A1 | AMINO NICOTINATE DERIVATIVES AS GLUCOKINASE (GLK) MODULATORS | ASTRAZENECA AB (SE) | 2003-01-03 | — | — | WO | disclosed |
| CN-1388412-A | Photo sensitive composition and negative lithographic printing plate | FUJI PHOTO FILM CO LTD (JP) | 2003-01-01 | — | — | CN | disclosed |
| US-20020146633-A1 | FLUORINATED AROMATIC ACETAL POLYMERS AND PHOTOSENSITIVE COMPOSITIONS CONTAINING SUCH POLYMERS | KODAK POLYCHROME GRAPHICS L.L.C. | 2002-10-10 | — | — | US | disclosed |
| US-6458503-B1 | BLEND WITH DIAZO RESIN; LITHOGRAPHIC PRINTING PLATES; PHOTOPOLYMERIZATION AND CROSSLINKING | KODAK POLYCHROME GRAPHICS LLC | 2002-10-01 | — | — | US | disclosed |
| WO-2002073315-A1 | FLUORINATED AROMATIC ACETAL POLYMERS AND PHOTOSENSITIVE COMPOSITIONS CONTAINING SUCH POLYMERS | KODAK POLYCHROME GRAPHICS COMPANY, LTD. (US) | 2002-09-19 | — | — | WO | disclosed |
| CN-1365368-A | Acrylic modified waterborne alkyd or uralkyd dispersions | EASTMAN CHEM CO (US) | 2002-08-21 | — | — | CN | disclosed |
| US-4051078-A | CURING | DAINICHI-NIPPON CABLES, LTD. (JA) | 1977-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11318129-B2 | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders | SLC10A1, SLC10A2, FABP3 | ALDH1A1 2512/4885ALOX15 1374/4885GAA 1585/4885 |
| US-20200268741-A1 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | SLC10A1, SLC10A2, FABP3 | ALDH1A1 2512/4885ALOX15 1374/4885GAA 1585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.